Systemic nocardiosis in a case of rheumatoid arthritis treated with tumor necrosis factor blockers.
Wendling
Daniel
D
Murad
Muhsen
M
Mathieu
Sandra
S
Berger
Eric
E
Rumbach
Lucien
L
D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002494:Central Nervous System Infections / Q000276:immunology / Q000382:microbiology*; D004359:Drug Therapy, Combination; D006801:Humans; D016867:Immunocompromised Host; D008279:Magnetic Resonance Imaging; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009617:Nocardia Infections / Q000209:etiology* / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab; D008727:Methotrexate